Strategies for improved cancer vaccines
The present invention concerns methods and compositions for forming anti-cancer vaccine complexes. In preferred embodiments, the anti-cancer vaccine complex comprises an antibody moiety that binds to dendritic cells, such as an anti-CD74 antibody or antigen-binding fragment thereof, attached to an AD (anchoring domain) moiety and a xenoantigen, such as CD20, attached to a DDD (dimerization and docking domain) moiety, wherein two copies of the DDD moiety form a dimer that binds to the AD moiety, resulting in the formation of the vaccine complex. The anti-cancer vaccine complex is capable of inducing an immune response against xenoantigen expressing cancer cells, such as CD138negCD20+ MM stem cells, and inducing apoptosis of and inhibiting the growth of or eliminating the cancer cells.
IBC Pharmaceuticals, Inc.
C C A A C B C C C A C A C C A A C C C
C07K C07K A61P A61K C07K B82Y C07K C07K C07K A61K C07K A61K C07K C07K A61K A61K C07K C07K C07K
inventional additional inventional additional additional inventional inventional inventional additional inventional inventional additional inventional additional inventional inventional additional additional inventional
Chien-Hsing David M.
Chang Goldenberg